LV10963B - Method of preparation of glycopeptide - Google Patents

Method of preparation of glycopeptide Download PDF

Info

Publication number
LV10963B
LV10963B LVP-94-18A LV940018A LV10963B LV 10963 B LV10963 B LV 10963B LV 940018 A LV940018 A LV 940018A LV 10963 B LV10963 B LV 10963B
Authority
LV
Latvia
Prior art keywords
quot
glycopeptide
nhac
result
groups
Prior art date
Application number
LVP-94-18A
Other languages
Latvian (lv)
Other versions
LV10963A (en
Inventor
Bistricenko Andrejs
Jermolajevs Jevgenijs
Original Assignee
Bistricenko Andrejs
Jermolajevs Jevgenijs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bistricenko Andrejs, Jermolajevs Jevgenijs filed Critical Bistricenko Andrejs
Priority to LVP-94-18A priority Critical patent/LV10963B/en
Publication of LV10963A publication Critical patent/LV10963A/en
Publication of LV10963B publication Critical patent/LV10963B/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

Obtaining glycopeptides after the disaccharide condensation reaction with protected peptide protective groups are split off with 4% formic acid in the presence of solvent: ethanol-water in 2:1 proportion. There is an absence of gaseous hydrogen; ready-to-use product outcome is 75%. The obtained glycopeptide may be used for medical, either veterinary, purposes.

Description

LV 10963 ,-'-γγ'λε π,λ ~7τ.ττττπ,Γσ ΓΤί/π^'/ΓπτττΦΜΤΐΛ i_J ii’-'ViU iX-.'AXJ/iJX X «V L U I 1 i - * 1 1 I. u t -mLV 10963, -'- γγ'λε π, λ ~ 7τ.ττττπ, Γσ ΓΤί / π ^ '/ ΓπτττΦΜΤΐΛ i_J ii' - 'ViU iX -.' AXJ / iJX X «VLUI 1 i - * 1 1 -m

M matr'TL; i-J1-/'-.·· M'-· i '-· ilJfi'.M matr'TL; i-J1 - / '-. ·· M'- i' - · ilJfi '.

ΟΤ.ΤΧΓΦιΖ,^ΤΓ /^ΤνΤ,Λ ΤΤΛΓτ^ΤΤΰ^ντ.Τ Οτ.'^τ Τ w ΊΠ 7 V ητλ nTrTTc.tr:,τα -i -f·».'*.'/ ·1·-· χαλταΤΙ :">/~0 TTTT^^.~,TC ,^ν.τ-ί vu'J '4-·λ— -ΟΤ.ΤΧΓΦιΖ, ^ ΤΓ / ^ ΤνΤ, Λ ΤΤΛΓτ ^ ΤΤΰ ^ ντ.Τ Οτ. '^ Τ Τ w ΊΠ 7 V ητλ nTrTTc.tr:,τα -i -f · ».' *. '/ · 1 · - · χαλταΤΙ: " > / ~ 0 TTTT ^^. ~, TC, ^ ν.τ-ί vu'J '4- · λ— -

f—Hf-H

CH20H CHtOH I ! ‘ / / 0 / 0--- 1/ V 0 / M 1 \ / s f ✓ \ / 1 HO I NHAc 1 [ NHAc ch3ch-c;:oi-nhrCH20H CHtOH I! '/ / 0/0 --- 1 / V 0 / M 1 / s f ✓ / 1 HO I NHAc 1 [NHAc ch3ch-c;: oi-nhr

pTĻS 701,- ΓΤΛΤΤΤί^π^ φ—J1H L,—X.’ Ω_7,_Τ;··τ1 ~ 7TrOT,i X" C ?,!Γι Τ’Ο E C-n !ļ(7pJJJT ]yjļi "ΐΠίΓΗ*2ji>iTGpa. Μοτ,τΛο ΓΓώώ Ο γτ,τ-^-τ.τλ/γμ· v i i'.· '_· Wt/U*wi-ŪIUa X . t ραΓτιρτ^,τ.τχχο'ηττττ p> νοττύ^τΐώ τ’η/ΓΜτπίΛΛ/τ,'ϊ ttv 4x £j'-· ^ ·_· υίίϋχΟ ϋ·_· XA./ ic. ηττο rrc.nc«jnM'* ->-τ '•,· c- - (-«γλρλ^ι: i T O Xi ^-Γα τλ^η^ιγιτλμ ,"νττΓ".η'Λ/*!^ / T ϊ τγ. rr.cam.-* γτ ··»**-?,τ *“Τ —>..'s -τ>Λ-ττ-τα ·_·χχ··_· _ ·_ ••-••i.i >. X ļ,.v ; #*4'w^w·- iUiL'.'ji'n \ ±. / Tl.r-v/'Ll'P i. ·_ /1 i 1' _ _ p_ ^ i Γ1 a- ’ Cj Γΐχ i ΡΓ cjrno η·- Λη V ρ vc.tt ūptjū tr /> ττα tr r» τ,τ p\ TfT τττ a τ ···*, r,r^'j*nci _·ρττ *? zr^jr^t i-'.· :-i* v:i:u i—! s ·„ ί_· iw L.J i'.u 'iv v i i-'j i •.'-.'il.LV-· Π---.-1 |J V IUU_l·-· a ·_· -_J _ _· uiu Hi/i-ji -.jaja ζ 05 ΒΚΧ02 προ,ϋτκτη , OJICJKKCCTb Η ΧΕΕΙΤ 8 JIΒ HC C Τ Β npouecca .KeiiGCTSTKCM -•Tojiee ccEčpmeHHcro no cpaoneHiis: co cnccodoM (I j encccda/2) ,b KOTCPCM B ΚΟΟΟΟΤΞΟ K DHOOHOOpV ΕΧΕ ΓΟ 8Γ0ΗΤ3 ΧΟΠΟΧΒΒΥΧΤ ,ΙΟΙΠβΗΤΟ-::0TūppeH:iJTb:acCoH&T,OEJioeTCH cpaEHaTejībsc ΗβΒκοοκιώ ΒΗΧοχίΟδηι π raioKe sjiht*jibhoctL· npouBcca.KpcMe τογο,πρΗΜβΗβΗΗθ raaoodpas. 2C Eonopona b cnocodaic tī }-(£') ycjiojKHHeT MacniTačHpoBaHHe npouecca. Ilsjib iipennojiaraef/icro noodpeTeHiiB-noBHiiiBHaie ξβχγγο χβχβξογο ΐΐρ·οζγ?:τ3, ynpo!iies-ia κ }!ΗΤ6Η0ΗφΗΚ8ΠΗΗ npcnecca.Sro Ξβχν? peaKnneit ηβξβιϊεπχεηηογόArticle 701, - ΓΤΛΤΤΤί ^ π ^ φ — J1H L, —X. ”Ω_7, _Τ; ·· τ1 ~ 7TrOT, i X " C ?,! Γι Τ'Ο E Cn! (7pJJJT) yings " ΐΠίΓΗ * 2ji > iTGpa. Μοτ, τΛο ΓΓώώ γ γτ, τ - ^ - τ.τλ / γμ · vi i '. ·' _ · Wt / U * wi-UiUa X. t ραΓτιρτ ^, τ.τχχο'ηττττ p > νοττύ ^ τΐώ τ'η / ΓΜτπίΛΛ / τ, 'ϊ ttv 4x £ j'- · ^ · _ · υίίϋχΟ ϋ · _ · XA. / ic. ηττο rrc.nc «jnM '* - > -τ' •, · c- - (-« γλρλ ^ ι: i TO Xi ^ -Γα τλ ^ η ^ ιγιτλμ, " νττΓ " .η'Λ / *! ^ / T τ τγ. Rr.cam .- * γτ ·· »** - ?, τ *“ Τ - > .. 's -τ > Λ-ττ-τα · _ · χχ ·· _ · _ · _ •• - •• ii > X., .V; # * 4'w ^ w · - iUiL '.' Ji'n. / Tl.rv / 'Ll'P i. _ 1 i 1 '_ _ p_ ^ i Γ1 a-' Cj Γΐχ i ΡΓ cjrno η · - Λη V ρ vc.tt j / / / g f f f τ r τ j / / f f *, r, r ^ 'j * nci _ · ρττ *? zr ^ jr ^ t i -'. ·: -i * v: i: ui—! s · "ί_ · iw LJ i'.u 'iv vi i-'ji • .'-. 'il.LV- · Π ---.- 1 | JV IUU_l · - · a · _ · -_J _ _ · uiu Hi / i-ji -.jaja ζ 05 ΒΚΧ02 προ , ϋτκτη, OJICJKKCCTb Η ΧΕΕΙΤ 8 JIΒ HC C Τ Β npouecca. cpaEHaTejībsc ΗβΒκοοκιώ ΒΗΧοχίΟδηι π raioKe sjiht * jibhoctL · npouBcca.KpcMe τογο, πρΗΜβΗβΗΗθ raaoodpas. 2C Eonopona b cnocodaic ti} - (£ ') ycjiojKHHeT MacniTačHpoBaHHe npouecca. Ilsjib iipennojiaraef / icro noodpeTeHiiB-noBHiiiBHaie ξβχγγο χβχβξογο ΐΐρ · οζγ?: Τ3, ynpo! Iies-ia κ}! ΗΤ6Η0ΗφΗΚ8ΠΗΗ npcnecca.Sro Ξβχν? headKnneit ηβξβιϊεπχεηηογό

XvIC3XāpIIX3 icpMPOH JI ; C ch2oh ch2ohXvIC3XāpIIX3 icpMPOH JI; C ch2oh ch2oh

/0 / o---H/ 0 / o --- H

!/ vd / M 40 1 \_/ ' /\ _/1 ili) HO ļ ļ ļ NHAc 0 NHAc i! / vd / M 40 1 \ _ / '/ \ _ / 1 ili) HOUSES NHAc 0 NHAc i

CH-CH-C!0)-OH 45CH-CH-C10) -OH 45

BauaniieHKHM γϊβιιτχχομ e ηριτοντοτΒζη ECHoeHcirpvoiiiero areK?a-.ΒίπβκτβφτορφβhiiJiKapdcHaτa c ncc.jieiiyo!iBiM ūTiiienneHiien Ξ3ΐίΐη?ΗΗΧ rpyrxi η KpoMaTorpainnecKoP: cblictkoīI ϊτροχρο:τ3. OTiiienjieniia 33xxthhx rpvnn npcsonHT οΧροίοτκοιί 4.%-ecž wypa-50 BbilHCii ESICJICTCŽ E ΒΟΧΗΟ-ΟΠίρΤΟΒΟΜ paCTEOpā ;ECX3/3Τ3Η0Χ-2 : 1 ) LV 10963 τ π-ρτΤί->ττΦ,-·ΓΠ·οτ.ΓΓ,τ firr'O πτ-rc οολτ',ci_rrci rr rc. niTamfl· 'jRļjHIT ’ίβΞ b .1 _ JL V. ,· 1 L- L i-'i'i-i 11U . Ui/lJ.iJU iu 'JU“UUi/WlUA«i'.lJU« * ~ i HĪIH raSC0dD23HCr0 EOJIOpOJia .BauanieHKHM γϊβιιτχχομ e ηριτοντοτΒζη ECHoeHcirpvoiiiero areK? A-.ΒίπβκτβφτορφβhiiJiKapdcHaτa c ncc.jieiiyo! OTiiienjiaiia 33xxthhx rpvnn npcsonHT οΧροίοτκοιί 4% - ecž wypa-50 BbilHCii ESICJICTCŽ E ΒΟΧΗΟ-ΟΠίρΤΟΒΟΜ paCTEOp; ECX3 / 3Τ3Η0Χ-2: 1) LV 10963 τ π-ρτΤί- > ττΦ, - · ΓΠ · οτ.ΓΓ, τ firr 'O πτ-rc οολτ', ci_rrci rr rc. niTamfl · 'jRljHIT' ßB1.1 JL V., · 1 L-L i-ii-i 11U. UI / J.iJu iu 'UUi / WlUA «i'.LJU« * ~ i HHI raSC0dD23HCr0 EOJIOpOJia.

3TH jCJTOBHH nGSBCJīH?jT ynpcCT5ITB līpOUeCC CīCiTesa, CHIISLiTB H20jjGJBKĪIT 8JIBHO C T b ĪIEOiieCCa II ĪĪOBHCĪITB ΒΗΧΟΙ Ιίβ-ΊΘΕΟΓΟ HpOXyKTS b ^ rr n 7 κ α ,μυ I ,.·ν . npiaiep ι .IIojiyT-ieHEe ν- aueTiuir jikkos aMHHKJi-N ’ - aue τ jī Jiwy paMHJi- l- ajīaKaji-D-K3orjiyTSM5iHa (ΓΜ2Π). srncMM) flncaxapiuia(2) pacTEopaKT b 100 mji nepernaHHoro3TH jCJTOBHH nGSBCJIHY ynpcCT5ITB liPOUeCC CiTiTes, CHIISLiTB H20jjGJBITi 8JIBHO C T bIiCiCiIiO II IOBHcITi ΒΗΧΟΙ Ιίβ-ΊΘΕΟΓΟ HpOXyKTS b ^ rr n 7 κ α, μυ I,. · Ν. nIiTiNiIiYe-ieHEeViNiTiTiOn aMHHKJi-N '- aue τ yi Jiwy paMHJIlIyYaKaji-D-K3orjiyTSM5iHa (ΓΜ2Π). srncMM) flncaxapiuia (2) pacTEopaKT b 100 mji does not passHHoro

60 ^ΗΪΛβΤΐυίφορΜβΜΗΑΒ. £0 ij aBJiaiO*!* 1 ( 2 M»jĪ ι. 1 1 1 'jiVliu j ^* ·Μ37«ΙJBtībP'ipOJBiiTiCĪ j/I60 ^ ΗΪΛβΤΐυίφορΜβΜΗΑΒ. £ 0 ij aBJiaiO!

a/ir (12,0 MM) ,ΙΓΙΠΙβΗΤ8φΤ0ρφβΚΙ'υΐΚ3ρ<ΐ0Η3Τ2 .IlepeMeniKEaiOT npn 1S-20* 30 ΜΙΊΚ 51 ĪIpMJIIiE3IQT paCTEGp 4.6 Γ (11,0 MM) ΤρΐΐφΤ0ρ31Ι8Τ2Ί;3 X-3JĪ3HIIJI-B-H30rJiyT3MHK3 Υ-0βΗ3ΐυΐ0Ε0Γ0 3$Iipa H 2,4 MJI (22.0 NlM) N-MeTKJIMOp$OJIEHa E 20 MJI SIM8TIIJI$CpM3MiIJT3. ΠθρθΜ8ΙΠΙ-ίΕ3Κ3Τ E Τ9Γ-Ι3-65 Hiie 5 q.paCTB0pHT8JIB ynapHB3I0T.K 0CT8EineMyCH M3CJiy npKJIHB3H5T 140 MJI IIIICTKJIJIirpCBaHHOii BOflEI.paCTBOp 9KCTparnpyiDT 2 *50 MJI ΓβΚ03Η3 , K EOflHOMy CJIOM ,HOC3EJIHīOT 70 MJI 3T3H0JI3, S MJI Myp3EBiīH0ft KilCJIOTH ,5 Γ najuiajmesofi τΙβρΗΙΊ II ΠβρβΝ!βΙΙΙΙί33Κ)Τ E Τβ’-ΙβΗΚβ 30 ΜΠΗ. IlOCJie OTJieJieHHH K3T3JM33TQp3 $IĪJIBTp3T ynapI-IB3iOT JļO ĪIOJIOEHHH Ό 00ΒβΜ2 K K3H0CHT H3 KOJIOHKy 00BēM0M 1 Jī. 00,Ιίβρ:Κ3ΕΐγΒ3 2ΗΙΙ0ΗΪΙΤ Ηa / ir (12.0 MM), ΙΓΙΠΙβΗΤ8φΤ0ρφβΚΙ'υΐΚ3ρ < ΐ0Η3Τ2 .IlepeMeniKEaiOT npn 1S-20 * 30 ΜΙΊΚ 51 BOOK E3IQT paCTEGp 4.6 Γ (11.0 MM) ΤρΐΐφΤ0ρ31Ι8Τ2Ί; Iipa H 2.4 MJI (22.0 NlM) N-TEMPERATURE $ OJIEHa E 20 MJI SIMRITIY $ CpM3MiIJT3. ΠθρθΜ8ΙΠΙ-ίΕ3Κ3Τ E-Τ9Γ Ι3-65 Hiie 5 q.paCTB0pHT8JIB ynapHB3I0T.K 0CT8EineMyCH M3CJiy npKJIHB3H5T 140 ml IIIICTKJIJIirpCBaHHOii BOflEI.paCTBOp 9KCTparnpyiDT 2 * 50 mL ΓβΚ03Η3, K EOflHOMy CJIOM, HOC3EJIHīOT 70 ml 3T3H0JI3, S mL Myp3EBiīH0ft KilCJIOTH, 5 Γ najuiajmesofi τΙβρΗΙΊ II ΠβρβΝ! βΙΙΙΙί33Κ) Τ E Τβ'-ΙβΗΚβ 30 ΜΠΗ. IlOCJie OTJieJieHHH K3T3JM33TQp3 $ IJIBTp3T ynapI-IB3iOT YOUNG YOUNG HH Ό 00ΒβΜ2 K K3H0CHT H3 KOJIOHKy 00BMMM 1 Yi. 00, Ιίβρ: Κ3ΕΐγΒ3 2ΗΙΙ0ΗΪΙΤ Η

’aTHOii φΟΕΜΘ . KOJIOHKV ITDOiVtHB3IOT 2,5 JI τττ.τ,-νπτ.τ ;τ rrjmr.r. r,zzxj,^-j ro^mr ^c.TuM c. ττϊλϊχτ^γιλφ η Γττκν/Λττατιττ.τττ “r,^ τττύυΦΛλ/ΐ -'‘Jl-ii·.· ϋ _···_ __χαχ * i’-iTi ·_· u j χ·,: x a v'ijiiV'JU·. i* _ j/iu _ > " ^ li, 1'i, ·— ,7= 1 ·_:.ν1 Λ 1 5';] γ:Λ ντ.τ,·-» γγλγγο ^c, τ,"ττο^Γ/Γτ:'^ΰΐττ·ζ rfvr αντττΛ-Vfr nr\ tcitvl*c< j :J_i w - ir.«l'.'»U··. J. _i . X * ·— l—· %J j ii 1 >-/χ·χ AJ ΑΧΑΪΚΑ J Λ. j < V-' f i i ' l i -j i -J I t 1W ·._·' J_L< — ttiTTv πιίττπ τ·τ τγγτπι-^τ,τ τττ,το c,rrT.m ΛΛΦοπίίο ττ/*> πνττονντ» κ λ τ ι τ - α, λ . ιαα*1_α -l :ΐί·.ί_ - 1/ν ν χΑχ·-1 fc.· χαα ·_* ūiu,JUi i. ’_j * IV_i u.ijJiV ·χ··_ι^_' a , *_ L κ < 9v .' χ ι·.Μ .· J, J i cojie^KamieM οοηοβηογο semecTEa 99,5% rno ,χβηηημ hplo .'ATHOii φΟΕΜΘ. HARDWARE ITDOiVtHB3IOT 2.5 JI τττ.τ, -νπτ.τ; τ rrjmr.r. r, zzxj, ^ - j ro ^ mr ^ c.TuM c. ττϊλϊχτ ^ γιλφ η Γττκν / Λττατιττ.τττ "r, ^ τττύυΦΛλ / ΐ - '' Jl-ii ·. · ϋ _ ··· _ __χαχ * i'-iTi · _ · new χ ·,: xa v'ijiiV ' JU ·. i * _ j / iu _ > " ^ li, 1, · -, 7 = 1 · _ :. ν1 Λ 1 5 ';] γ: Λ ντ.τ, · - »γγλγγο ^ c, τ, " ττο ^ Γ / Γτ:' ^ ΰΐττ · ζ rfvr αντττΛ-Vfr nr citvl * c < j: J_i w - is. «l '.'» U ··. J. _i. X * · - l— ·% J j ii 1 > - / χ · χ AJ ΑΧΑΪΚΑ J Λ. j < V- 'f i i i i-j i t 1W · ._ ·' J_L < - ttiTTv πιίττπ τ · τ τγγτπι- ^ τ, τ τττ, το c, rrT.m ΛΛΦοπίίο ττ / * > πνττονντ »κ λ τ ι τ - α, λ. ιαα * 1_α -1: ΐί · .ί_ - 1 / ν ν χΑχ · -1 fc · χαα · _ * iu iu iu iu iu iu iu '_J * IV_i u.ijJiV · χ ·· _ι ^ _' a, * _ L κ < 9v. , ι · .Μ. · J, J i cojie ^ KamieM οοηοβηογο semecTEa 99.5% rno, χβηηημ hplo.

OipaSLIH ΓΜ,ΐυΐ aHSJIIiSiipCBaJIHCB Χρ0Μ3Τ0Γρ3φΐ·ΓίβCKH (HPLC.COHeOipaSLIH ΓΜυΐ aHSJIIiSiipCBaJIHCB Χρ0Μ3Τ0Γρ3φΐ · ΓίβCKH (HPLC.COHe

Topfm Λ/^ηηοΛΑ,ι ncio-pc/ornou ηχΎη.ηΓΎ\ ρτπίΦοοίΐ ή τπτν^τΤΰΐΓΓΤ»ττπ<ΜTopfm ^ / ^ ηηοΛΑ, ι ncio-pc / ornou ηχΎη.ηΓΎ ττπίοοίΐ ή τπτν ^ τΤΰΐΓΓΤ »ττπ < Μ

ΧΑα£\.*Χ^Ι W'JWWi»l » ļ-Χ 1J >X- U Ai >Xlw A Uii AA-_-AXXij<A U'iiuU'U'.1 L-Ai-Li A X· IX AJ A yt ΑΛΑΧΛ Uļi>.‘ i A X. Af ΑΧΑ AΧΑα £ * * Χ ^ Ι W'JWWi »& Χ 1J > X-U Ai > Xlw A Uii AA -_- AXXij < A U'iiuU'U L-Ai-Li AX · IX AJ A yt ļi Rocks >.

$OpMyjIH ί 1 5 . OTJUriažDfflMCH OT CnOCOČa-ripCTOTMna HCII0JIB3CB3HK8M$ OpMyjIH ί 1 5. OTJUriažDfflMCH OT CnOCOČa-ripCTOTMna HCII0JIB3CB3HK8M

Op- o LOīTDfirntiū ττοΡ ΓΓ/'Μντ.ΓητΓΊΛτττατι^'. c>-p,Dt;mc> λ οι ιΐ/ΎΓΐ n*\mc« — νττ("> rrr'rnt: - J-J iu'.J "ΑΆ '·—·' A i-J1—· i,1. iUU-i,··-· -i. -X Ui ’.'AH-J *+ .· V — Π ·-/ λ A HH rJ'.iAa.JUl-XiU A '.ML WWA'-_· i _'i XJ r>T.<rr>rnci:uic. γορπέλπιτίιο rr^f> urpcitm π όγ\τγο i . o '-_· J A ‘_· i _· IV1X *_· i Χ-Γ·—1 iAJiA A ’_-*/i'_-AfA -X A AU'-Jv'i — ( « C_Ops LOīTDfirnti ττοΡ ΓΓ / 'Μντ.ΓητΓΊΛτττατι ^'. c > -p, Dt; mc > λ οι ιΐ / ΎΓΐ n * Mc «- νττ (" > rrr'rnt: - JJ iu'.J " ΑΆ '· - ·' i i-J1— · i, iUU-i, · · - · -i-X Ui '.'AH-J * +. · V - Π · - / λ A HH rJ'.iAa.JUl-XiU A' .ML WWA '-_ · i _i XJ r > T. < rr > rnci: γορπέλπιτίιο rr ^ f > urpcitm π όγ τγο i. o '-_ · AND' _ · i _ · IV1X * _ · i Χ-Γ · —1 iAJiA A ' _- * / i '_- AfA -XA AU'-Jv - («C_

OcpiecTBJieHsie rioeiīJiaraeMGro cnocoda nosEOJineT ποβηοζτβ BE KO E, i’fJUUl H3 10¾ M VIIpOCTI1TB IIpGLieCC ero ΠΟΛΏΘΗΚΑ. ftC. ΤΤΡίΎΓΠΦΤΛΤΤThe difference between the MGro cnocoda and the C oda oda oda oda oda oda EO T 3 3 3 3 3 ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ¾ ftC. ΤΤΡίΎΓΠΦΤΛΤΤ

AAAAAA

ΛΰΤ,Τ ΤΤΛ fT^C. rTp.prnn<p ηρτ.ΤΓΓΟΓτη πτ.Γ»φ·ε^ ·_· AĀjiAAA·-· X L/U T Cfir; Γ. N ^971^/1 o* A. x-· f / ir~- l “X T Q.Qr/ A. - ! r> tm A A'4 1 7 0C. IfļO T !\ t>rpri"r,,*>vno A. · ΠΑ A L!l-Av>J>.' 9 ļciTiAnoif'''.ū P_- xii_J A w LJ'-.-A1-1-”-· LV 10963 *=·;' TM7 ~ ·*· 7 P7 v;7^*?Τ.Γ r.:: -fc.··. - .v:·.· ·.··__·“i x i. —; _ ^_4. *_; - LH-,ΟΗ i_.: / 0 | /ΛΰΤ, Τ ΤΤΛ fT ^ C. rTp.prnn < p ηρτ.ΤΓΓΟΓτη πτ.Γ »ji ε · Ā ji ji ji AA · - - - - - L L L L . N ^ 971 ^ / 1 o * A. x- f / and ~ - l “X T Q.Qr / A. -! r > tm A A'4 1 7 0C. If you want to know what you are looking for? Ci ci ii ii no no if if w ū _ _ ii -1 -1 -1 if w w ū ū A1 -1 -1 -1 -1 -1 if w 9 TM7 ~ · * · 7 P7 v; 7 ^ *? Τ.Γ r. :: -cc ··. - .v: · · ·. ·· __ · "i x i. -; _ ^ _4. * _; - LH-, ΟΗ i_ .: / 0 | /

ch2oh / 0---H ν' c / M / '/\ __ I _/ ! | i HAc 0 1 NHAc 1 CHgCH -C;G:-NHPch2oh / 0 --- H ν 'c / M /' / \ __ I _! | i HAc 0 1 NHAc 1 CHgCH -C; G: -NHP

HD 1 !HD 1!

MM

HH

ΓΟΟ Ι-ΓΗ?.- . ' . *> .-τ' -τι nsisa -iCDMVJIH L-Aia 332āLVIC 23 :7? sīc CiACĪ 1+7- vi’!,1; ^ lJS C : CH I aGH CH i 20H i / 0 1 t / 1 0 1 i 1 X !/ ν' c / M i V J V ' /\ / ! HO I i i 1 1 1 NHAc 0 ļ NHAc 1 ch3ch -C D,-CHΓΟΟ Ι-ΓΗ? .-. '. * > .-τ '-τι nsisa -iCDMVJIH L-Aia 332aLVIC 23: 7? ss CiACi 1 + 7- vi '!, 1; 1JS C: CHI aGH CH i 20H i / 0 1 t / 1 0 1 i 1 X! / ν 'c / M i V J /' \ t HO I i 1 1 1 NHAc 0 l NHAc 1 ch3ch -C D, -CH

: 3 GiiiSiič 3330.! ~ 3::ΐΓ3ΗΓ37Τ..3ί ; H χΗοηειχ rpvnn :ī :τ3ΐΐΐ333ίαΐπί:Η τ nHOSOniĪSSLOO: 1 --rrr ΙΠ0Μ Z . *' S Ci ‘ 3301303 ~»Ί ~· ,-·. 7- r 1 rri ·_· *' i - ' - " η. η. r ,-¾ rn· 3C..0 hsts’si : :ī-obt:i nnšnc ,ηΐΗ ,0 0 ...0::-:03:3 ., ļ :3 ••7- CMST ΟΟΟΟφϊΓΟ -:·οκοί : *o:: ::·: ·—· .J i. uejie ecoc :n *33' TO ’-ITC C ZiJice.· ΓΙΟ 322 3H02 Ξ nno U ļ ynoonoo iln li CUē C oone: nmono; c 3’·::ττ Zir.iA n *- · r~^“~ •rrr' - s - :T -::¾ :/Γ:'3 333113::: :··τ· - ··.' on: ·"’ sīc 1 » . ' - ·'/ i*:7 Τ'· ^ -f- — — o::oo, oe: 3 GiiiSiič 3330! ~ 3 :: ΐΓ3ΗΓ37Τ..3ί; H χΗοηειχ rpvnn::: τ3ΐΐΐ333ίαΐπί: Η τ nHOSOYLOO: 1 --rrr ΙΠ0Μ Z. * 'S Ci' 3301303 ~ »Ί ~ ·, - ·. 7- r 1 rri · _ · * 'i -' - " η. η. r, -¾ rn · 3C..0 hsts'si:: pi-obt: i nnšnc, ηΐΗ, 0 0 ... 0 :: -: 03: 3,,: 3 •• 7- CMST ΟΟΟΟφϊΓΟ -: · Οκοί: * o :: :: ·: · - · .J i. uejie ecoc * 33 'TO' -ITC C ZiJice. c 3 '· :: ττ Zir.iA n * - · r ~ ^ “~ • rrr' - s -: T - :: ¾: / Γ: '3 333113 :::: ·· τ · - ··. ' on: "" · · I * 7 7ΤΤ ^ -fff o ° oo, oe

BAD ORIGINALBAD ORIGINAL

Claims (1)

LV 10963 IZGUDROJUMA FORMULA G1 ikopept'i da:GB 10963 FORMULA G1 Iconopeptide of the Invention: OH R iegūšanas metode, Kur MMR" pecti ua at i i kūms l.—Ala-D—iGiu, savstarpe j i iedarDonaties cusanuri aam:OH R Acquisition Method, Where MMR " pecti ua at i kūmas l. — Ala-D — iGiu, mutually doDonaties cusanuri aam: OH ar aizsargāto peptī du α rejams ka s k i di naca ja dipent ai- iuori-eni Ikarbonāta un N—met i lmor-Pol ī na klātbūtni; ar aizsargāto grupu atšķelšanu un gala produkta nromatoar at· i sko ar. c.ΐ r i s iznākumu, vienkāršotu un mtensi grupas atšķel apstrādājot ar 4¾ nu., atšķiras ar to, ka, lai palielinātu icetu iegūšanas procesu, aizsargātās Kudrsrābi s«?:i cunātši ju sistēmā etanols-ūdens 1s 2.OH with the protected peptide α is thought to be the result of the presence of iciphenylate and N-methylmor-Polane; by separation of protected groups and nromatoar of the final product distinguished by. c.ΐ r i s result, the simplified and mtensi groups are cleaved by treatment with 4¾ nu.
LVP-94-18A 1994-01-20 1994-01-20 Method of preparation of glycopeptide LV10963B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LVP-94-18A LV10963B (en) 1994-01-20 1994-01-20 Method of preparation of glycopeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-94-18A LV10963B (en) 1994-01-20 1994-01-20 Method of preparation of glycopeptide

Publications (2)

Publication Number Publication Date
LV10963A LV10963A (en) 1995-12-20
LV10963B true LV10963B (en) 1996-04-20

Family

ID=19735703

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-94-18A LV10963B (en) 1994-01-20 1994-01-20 Method of preparation of glycopeptide

Country Status (1)

Country Link
LV (1) LV10963B (en)

Also Published As

Publication number Publication date
LV10963A (en) 1995-12-20

Similar Documents

Publication Publication Date Title
Malley et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection
DK0950068T3 (en) Collagen-binding protein compositions and methods of use
BR0208944A (en) streptococus pneumoniae open reading frames encoding polypeptide antigens and their uses
ATE410441T1 (en) COMPOSITIONS AND METHODS FOR TREATING INFECTIONS USING INDOLICIDINE ANALOGUES
ATE232109T1 (en) SYNTHETIC MULTIPLE TANDEM REPEATS OF MUCIN PEPTIDE AND ITS DERIVATIVES AND THEIR USE
DE69412250D1 (en) Rigid-rod polymer containing pyridobismidazoles
WO2006006195B1 (en) Antibacterial peptides and analogues thereof
CN102076359A (en) Vaccine compositions and methods
WO2002034773A3 (en) Streptococcal genes
PT914437E (en) IDENTIFICATION AND CLONING OF A MYCOBACTERIAL ANTIGEN CORRESPONDING TO HEMAGLUTININE FROM LIGACAO TO HEPARINA
LV10963B (en) Method of preparation of glycopeptide
NO20011537L (en) Chemokine receptor peptide vaccines for the treatment and prevention of diabetes
GB2441094A (en) Methods for treatment and prevention of infection
JP7345933B2 (en) Alcohol-containing composition
ATE442858T1 (en) NUCLEIC ACID ADJUVANTS
JP2001220464A5 (en)
US11648289B2 (en) Antibacterial method
KR960705582A (en) Vaccine Design and Production
JP2895572B2 (en) Cosmetic and external preparation for skin
Holtzer Application of Old and New Values of. alpha.-Helix Propensities to the Helix-Coil Transition of Poly (L-glutamic acid)
AU2002231848A1 (en) Immunogenic glycopeptides, screening, preparation and uses
RU96112189A (en) CONSTRUCTION AND RECEIVING A VACCINE
DK1159426T3 (en) Cloning and expression of Haemophilus somnus transferrin-binding proteins
WO2002026240A3 (en) Inhibition of antigen presentation with poorly catabolized polymers
Moriishi et al. Inhibition of listeriolysin O-induced hemolysis by bovine lactoferrin